Embla Medical hf. (OTCMKTS:OSSFF – Get Free Report) is expected to be posting its resultson Tuesday, July 21st. Analysts expect Embla Medical hf. to post earnings of $0.0555 per share and revenue of $255.36 million for the quarter.
Embla Medical hf. Stock Performance
Shares of Embla Medical hf. stock opened at $4.15 on Friday. The company has a fifty day simple moving average of $4.15 and a 200-day simple moving average of $4.51. Embla Medical hf. has a 12-month low of $4.15 and a 12-month high of $5.33.
About Embla Medical hf.
Embla Medical hf., headquartered in Reykjavik, Iceland, develops and manufactures diagnostic medical devices for sleep, respiratory and neurophysiological monitoring. The company is publicly listed on Nasdaq Iceland and trades in the United States on the OTC market under the symbol OSSFF.
Embla Medical’s engineering and R&D teams design comprehensive solutions that combine hardware, sensors, electrodes and analysis software. Its portfolio includes ambulatory sleep assessment systems suitable for both in-lab and home-based polysomnography, as well as open-platform devices capable of capturing bioelectrical signals such as EEG, ECG and respiratory effort.
Beyond sleep diagnostics, the company’s technology supports respiratory care monitoring and neurophysiology research.
Featured Articles
- Five stocks we like better than Embla Medical hf.
- Netflix May Be Cheap Enough to Tempt Buyers After Earnings Drop
- Delta vs. United: Which Airline Is Better Built for Higher Fuel Costs?
- The Market Sold Alcoa After Earnings—But It May Be Missing the Real Story
- Why Intuitive Surgical’s Strong Quarter Still Spooked Investors
Receive News & Ratings for Embla Medical hf. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Embla Medical hf. and related companies with MarketBeat.com's FREE daily email newsletter.
